Lysozyme dimer and compositions containing the same

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/47 (2006.01) A61K 9/08 (2006.01) A61L 15/32 (2006.01) A61L 15/38 (2006.01) C12N 11/02 (2006.01)

Patent

CA 2140140

ABSTRACT OF THE DISCLOSURE The invention relates to new uses of the dimerised form of lysozyme for the manufacture of a medicament for inhibiting biosynthesis of Tumor Necrosis Factor in animals and humans. The lysozyme dimer is in particular useful for the treatment and prophylaxis of diseases associated with excessively high levels of Tumor Necrosis Factor. The invention further relates to pharmaceutical formulations of the medicament according to the invention, namely injections comprising the dimersed form of lysozyme in amounts of 0,01- 10 mg/ml, of an apyrogenic sterile composition comprising at least one physiologically acceptable solvent and at least one pharmaceutically approved preservative, as well as to tampons and antiseptive dressings impregnated with, and ointments or gels comprising an effective dose of the dimerised form of lysozyme for the prevention and/or treatment of sepsis and septic shock, especially of infected wounds.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Lysozyme dimer and compositions containing the same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lysozyme dimer and compositions containing the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lysozyme dimer and compositions containing the same will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1891040

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.